Five-Year Extension Results of the Phase 1 START Trial of Onasemnogene Abeparvovec in Spinal Muscular Atrophy

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

JAMA Neurology

Topics

Physics

Neuroscience

Medicine

Optics

Internal Medicine

Show all topics

DOI

10.1001/jamaneurol.2021.1272

License

CC-BY-NC-ND